HCC and Molecular Targeting Therapies: Back to the Future

HCC and Molecular Targeting Therapies: Back to the Future

Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have reduced HCC’s incidence, while non-alcoholic steato-hepatitis is an emerging risk factor. This review focuses on antiangiogen...

Full description

Bibliographic Details
Main Authors: Luca Rinaldi, Erica Vetrano, Barbara Rinaldi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Ferdinando Carlo Sasso
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomedicines
Subjects:
liver
HCC
drugs
trials
Online Access:https://www.mdpi.com/2227-9059/9/10/1345

Similar Items

Similar Items